Updated Jul 17, 2026
Hayward Marshall A. has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Hayward Marshall A. appears in the most recent SEC filing dated 2026-06-05 as Chief Scientific Officer of Jupiter Neurosciences, Inc. The filing context identifies him as the CSO, implying leadership over scientific strategy, research and development programs, and the neuroscience pipeline for the company. Public biographical details (education, career history, awards) are not provided by the SEC filing alone, and name variations (e.g., John Hayward, Hayward M. A., etc.) can exist in public records. This entry synthesizes the role and company information from the SEC context while noting the limited public biographical data available.
| Role | Chief Scientific Officer, Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | JUNS | JUPITER NEUROSCIENCES, INC. | M — Option exercise | 225.0K | — | |
| 2026-07-13 | JUNS | JUPITER NEUROSCIENCES, INC. | M — Option exercise | 399.4K | — | |
| 2026-07-13 | JUNS | JUPITER NEUROSCIENCES, INC. | M — Option exercise | 389.8K | — |
Hayward Marshall A. appears in the most recent SEC filing dated 2026-06-05 as Chief Scientific Officer of Jupiter Neurosciences, Inc. The filing context identifies him as the CSO, implying leadership over scientific strategy, research and development programs, and the neuroscience pipeline for the company. Public biographical details (education, career history, awards) are not …
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hayward Marshall A. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.